Peripheral Neuropathy—The Next Mega Trend in Chiropractic?

If you’re like most physicians I talk to, practice is not as good as it used to be. Insurance reimbursements continue to shrink, and with the Affordable Care Act are taking effect, many doctors are losing a lot of sleep!

Not me—I am sleeping like a baby because I’ve implemented the treatment of peripheral neuropathy in my practice, and it has been one of the most rewarding and profitable decisions I have ever made! I have helped hundreds of patients suffering with a debilitating condition that their own physicians said couldn’t be helped.

What is so special about the neuropathy niche?

There’s virtually no competition

MDs hate dealing with neuropathy patients because they don’t have many tools in their arsenals. Medications like Lyrica, Gabapentin, and Cymbalta can help mask some of the symptoms, but doctors know the drugs aren’t truly healing the condition.

This is not like fighting for a piece of the back pain market where you’re up against spine surgeons, pain management doctors, chiropractors, physiatrists, physical therapists, acupuncturists, and virtually every doctor on the block!

When you offer patients a logical, rational solution to treat the root of the problem, the response is amazing. Peripheral neuropathy sufferers respond to your marketing in droves because no other doctors have given them any hope for their condition.

This problem is not going away any time soon

If you have ever studied trend forecasting, you know that the aging baby boomer generation is presenting our nation with an epidemic of obesity, Type II diabetes, and neuropathy like we’ve never seen.

Unfortunately, the trend of the aging baby boomers means the number of patients with peripheral neuropathy will continue to skyrocket. Americans are not getting more fit and healthy every year….quite the opposite!

Because neuropathy is so often linked with Type II diabetes, it’s safe to say that unless we experience a dramatic lifestyle revolution, you will not be running out of patients in the foreseeable future.

You’ll have rock solid confidence in your clinical outcomes

With a properly-targeted neuropathy exam, you’ll be able to quickly and confidently determine which patients are candidates for the treatment, and which ones are not likely to respond.

This is an asset that I believe will change not only how you treat neuropathy patients, but will transform your confidence and how you view your practice. When you know there is an abundance of new patients in your community that need your help and are willing to pay for it, you won’t find yourself agonizing over every new patient and whether you’re going to convince them to start treatment.

You’ll know that you offer a solution that will change their lives, and you can deliver your care with confidence, certainty, and integrity.

Minimal doctor time is required to implement my neuropathy treatment protocols

Whether you realize it or not, your time is the single most valuable asset you possess. Many doctors reach a plateau and can’t break through to the next level because they don’t learn how to properly delegate and leverage the highest and best use of their time.

From a business standpoint, adding the neuropathy niche to your practice will be a decision that won’t require you to burn the candle at both ends and run yourself into the ground.

The clinical protocols to treat neuropathy only involve about 1-2 minutes per patient of doctor time. The modalities that you’ll learn to use can be administered by your staff, and do not require constant supervision. They can truly “set it and forget it”!

The treatments you’ll be doing are grounded in peer-reviewed clinical research and will allow you to get consistent, predictable results.

Neuropathy patients respond to advertising like nothing you’ve ever seen

A common refrain I hear from doctors that I encounter across the country is:

“I don’t do any advertising for my practice”

This is usually said with their chest puffed out and chin held high, as if it’s a badge of honor that they don’t have a budget for external advertising in their practice. I’ve heard that for years, but it was only recently that I figured out why this attitude troubled me so much.

Have you ever heard of Herschel Walker? He was one of the best running backs in the history of college football and was a physical specimen, yet was widely known for not lifting weights like the rest of his teammates. He had so much natural talent and ability that he could achieve at a high level without setting foot in the weight room.

This is exactly what some of you are! You’ve achieved benchmarks of success and productivity despite never doing the “heavy lifting” of external advertising or marketing. Can you imagine the number of patients you could serve and the income you’d earn if you were leveraging quality direct response marketing in your practice? Kudos to you if you have built your practice to a level that you’re content with, but wouldn’t it be nice to make twice as much money and retire twice as quickly?

Or, if it’s not money that motivates you, wouldn’t it be amazing to be able to help twice as many people? I may not be an advocate of building a practice solely on external marketing, but it can dramatically accelerate your path to success, however you define it.

Because these patients are so hungry for any type of quality treatment options, neuropathy patients will have your phone ringing off the hook when you run effective newspaper ads, radio campaigns, or other types of marketing.

It is also much easier to target your marketing efforts since nearly all of your neuropathy patients will be 65+. There is no “shotgun” approach in regards to demographics—you simply focus your efforts!

Dr. Jonathan Walker is in full-time private practice in Ocala, FL focusing on peripheral neuropathy and personal injury. He teaches doctors how to implement the neuropathy niche in their practice from A-to-Z clinical training and turnkey marketing with his Neuropathy Elite program. Reach Dr. Walker directly at 904-616-1284 with any questions or feedback.